Moore Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,000
| Closed | -$792K | – | 839 |
|
|
2021
Q1 | $792K | Sell |
25,000
-25,000
| -50% | -$792K | 0.01% | 503 |
|
|
2020
Q4 | $2.32M | Sell |
50,000
-169,982
| -77% | -$7.89M | 0.03% | 322 |
|
|
2020
Q3 | $7.24M | Buy |
219,982
+169,982
| +340% | +$5.6M | 0.14% | 123 |
|
|
2020
Q2 | $1.37M | Buy |
50,000
+25,000
| +100% | +$687K | 0.04% | 188 |
|
|
2020
Q1 | $748K | Sell |
25,000
-111,040
| -82% | -$3.32M | 0.03% | 129 |
|
|
2019
Q4 | $3.77M | Buy |
136,040
+12,441
| +10% | +$344K | 0.12% | 146 |
|
|
2019
Q3 | $2.25M | Buy |
123,599
+48,599
| +65% | +$885K | 0.09% | 184 |
|
|
2019
Q2 | $1.84M | Sell |
75,000
-75,000
| -50% | -$1.84M | 0.04% | 208 |
|
|
2019
Q1 | $1.43M | Hold |
150,000
| – | – | 0.04% | 204 |
|
|
2018
Q4 | $1.33M | Buy |
150,000
+25,000
| +20% | +$221K | 0.05% | 152 |
|
|
2018
Q3 | $1.41M | Buy |
125,000
+75,000
| +150% | +$844K | 0.03% | 176 |
|
|
2018
Q2 | $640K | Buy |
+50,000
| New | +$640K | 0.02% | 197 |
|